Difference between revisions of "Talk:Main Page"

From Clinfowiki
Jump to: navigation, search
(Kareo EHR: new section)
 
(One intermediate revision by one user not shown)
Line 1: Line 1:
=== Objectives ===
+
== Kareo EHR ==
  
Many computerized physician order entry (CPOE) systems have integrated clinical decision support (CDS) with the potential to reduce medication errors and improve patient safety. The article looks at how physicians handle safety alerts when medication orders are processed. The review focuses mainly on the conceptual analysis of the determinants of overriding drug safety alerts.  
+
==History==
 +
The Kareo EHR is owned by Kareo which was founded in 2004 by Don Rodrigues <ref name=’kareo_overview’> Kareo Company Overview: Bloomberg Businessweek</ref>. The EHR system is part of a cloud based SaaS platform. It achieved stage 2 Meaningful Use in 2014 <ref name=’mu’>Meaningful Use certification:http://oncchpl.force.com/ehrcert/Home</ref>
  
=== Research Questions ===
+
==Clinical Applications==
 +
The platform has the following features <ref name=’kareo_website’>Features: http://www.kareo.com/ehr#features</ref>
 +
* Comprehensive Dashboard
 +
* Simple Charting
 +
* ePrescribing
 +
* eLabs
 +
* Electronic Superbills
 +
* Integrated Patient Portal
 +
* Secure Messaging
  
The authors posted the following questions: “How often and in what situations are safety alerts overridden? Why do physicians override them? What effects ensue? What understanding of alert overrides can lead to improved alerting systems?”
+
==References==
 +
<references/>
  
=== Methods ===
+
[[Category:EHR]]
 
+
The authors searched for literature on publications involving CPOE on Medline and Embase databases from January 1980 to December 2004. They examined and identified publications addressing overriding of drug safety alerts during medication order processing. Seventeen publications on overriding safety alert in CPOE were selected and nine provided quantitative information on overriding.
+
 
+
=== Results ===
+
 
+
Safety alerts are overridden 49% to 96% of cases with lower override rates for drug interactions and contraindications. Though not completely confirmed, some studies showed that low-level alerts appeared to be overridden more often than high-level alerts. Drug renewals, drug interactions with topical drugs and poorly defined drug allergies were among those with high override rates. Adverse events were observed in 2.3% to 6% of overridden alerts.
+
 
+
=== Conclusion ===
+
 
+
CDS when integrated with CPOE systems improve patient safety by reducing medication errors through safety alerts. Alerts, depending on whether they are justified or unjustified, low or high specificity and sensitivity, could cause adverse events when overridden. Too many unnecessary safety alerts will cause alert fatigue and increase overrides. If poorly designed, decision support in CPOE can compromise patient safety. Improving alerting will decrease overriding and improve safety. Alerts need to be monitored, should have high specificity and sensitivity, do not unnecessarily interfere with workflow, and should have clear information.
+

Latest revision as of 00:51, 8 September 2015

Kareo EHR

History

The Kareo EHR is owned by Kareo which was founded in 2004 by Don Rodrigues [1]. The EHR system is part of a cloud based SaaS platform. It achieved stage 2 Meaningful Use in 2014 [2]

Clinical Applications

The platform has the following features [3]

  • Comprehensive Dashboard
  • Simple Charting
  • ePrescribing
  • eLabs
  • Electronic Superbills
  • Integrated Patient Portal
  • Secure Messaging

References

  1. Kareo Company Overview: Bloomberg Businessweek
  2. Meaningful Use certification:http://oncchpl.force.com/ehrcert/Home
  3. Features: http://www.kareo.com/ehr#features